Skip to content

Drug interactions

Lemborexant + Nilotinib

Severity: Moderate

Lemborexant and Nilotinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nilotinib inhibits CYP3A4 and may increase lemborexant exposure. This can increase next-day somnolence and impaired psychomotor performance.

What this interaction means in plain words

Lemborexant and Nilotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lemborexant belongs to Central Nervous System; Nilotinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Nilotinib inhibits CYP3A4, the main metabolic pathway of lemborexant.

What to do

Limit lemborexant to the lower recommended dose when given with weak CYP3A4 inhibitors. Monitor for daytime drowsiness.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lemborexant and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lemborexant with Nilotinib?

MediHelp rates the interaction as moderate. Lemborexant and Nilotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nilotinib inhibits CYP3A4 and may increase lemborexant exposure. This can increase next-day somnolence and impaired psychomotor performance.

How serious is the interaction between Lemborexant and Nilotinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Limit lemborexant to the lower recommended dose when given with weak CYP3A4 inhibitors. Monitor for daytime drowsiness.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in